CVSA
Covista Inc.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA margin non-GAAP | 26.3% | Q3 FY2026 | — |
|
|
|||
| Net leverage | 0.7 | As of Mar. 31, 2026 | — |
| Adjusted EBITDA non-GAAP | $154.9M | Q2 FY2026 | — |
| Total student enrollment | 97,010 | Q2 FY2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Education & Training Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CVSA
this stock
Covista Inc.
|
$4.42B | +25.5% | +12.9% | — | 4.8% |
|
EDU
New Oriental Education & Technology Group Inc.
|
$7.84B | -14.5% | +13.6% | — | 0.2% |
|
LAUR
Laureate Education, Inc.
|
$5.35B | +13.5% | +19.5% | 20.4 | 3.7% |
|
LOPE
Grand Canyon Education, Inc.
|
$4.05B | -8.2% | +19.8% | 19.1 | 6.5% |
|
LRN
Stride, Inc.
|
$3.85B | +39.3% | -8.0% | — | 15.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CVSA | +4.6% | +5.5% | +14.8% | +4.2% | +25.5% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +3.2% | +6.8% | +6.8% | +4.5% | +16.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.